Search Results
Jan 08, 2026, 09:23 ET CONVENE HOSPITALITY GROUP HIRES HOSPITALITY BRAND BUILDER JACQUE RILEY TO SUPPORT GROWING HOUSE OF LIFESTYLE BRANDS
Simonetti, president and CEO of CHG. "Jacque's deep hospitality brand-building experience, sense of storytelling, and eye for differentiation sets us up to seed strong emotional connections to multiple lifestyle brands as we expand to meet the white space in the market." Riley brings more than 15 years
More news about: Convene Hospitality Group
Jan 08, 2026, 09:19 ET CONVENE HOSPITALITY GROUP HIRES HOSPITALITY BRAND BUILDER JACQUE RILEY TO SUPPORT GROWING HOUSE OF LIFESTYLE BRANDS
Simonetti, president and CEO of CHG. "Jacque's deep hospitality brand-building experience, sense of storytelling, and eye for differentiation sets us up to seed strong emotional connections to multiple lifestyle brands as we expand to meet the white space in the market." Riley brings more than 15 years
More news about: Convene Hospitality Group
Jan 08, 2026, 09:00 ET Francelys Infante Launches N2B4B: A Holistic Self-Care Brand Rooted in Resilience and Self-Worth
Ascorbic Acid, Punica Granatum (Pomegranate) Fruit Extract (and) Decaffeinated Camellia Sinensis (Green Tea) Leaf Extract (and) Vitis Vinifera (Grape) Seed Extract in Glycerin, Hyaluronic Acid (as Sodium Hyaluronate)Other Ingredients: Water, Hydrolyzed Collagen Peptides, Malic Acid, L-Citrulline,
More news about: N2B4B
Jan 08, 2026, 03:30 ET Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
group of investors including BGF, Eli Lilly and Company, IQ Capital, Meltwind, M Ventures, Octopus Ventures, Pioneer and UK Innovations & Science Seed Fund. For further information visit https://www.nanosyrinx.com/
More news about: NanoSyrinx
Jan 08, 2026, 03:00 ET TECregen Raises CHF 10 Million in Seed Financing and Appoints Dr. Bo Rode Hansen as Chairman
biotechnology company pioneering thymus regeneration, today announced the successful completion of a CHF 10 million (∼EUR 10.7 million / USD 12.6 million) seed financing round. The financing was led by the Boehringer Ingelheim Venture Fund (BIVF), with participation from LifeSpan Vision Ventures, Carma Fund,
More news about: TECregen AG
Jan 08, 2026, 01:41 ET ROBOTERA Showcases Its "Hexa-Core" Robotics Lineup at CES 2026
such as Skild AI, Humanoid AI, and Extend Robotics, as well as top universities and research institutions including UC Berkeley, MIT, and ByteDance Seed. Hardware Portfolio Highlights From L7's powerful and dexterous full-body performance, to Q5's ultra-human-like presence, and XHAND1's
More news about: ROBOTERA
Jan 07, 2026, 10:00 ET ZIEGLER CLOSES $37,840,000 FINANCING FOR THE SANCTUARY AT VILLAGE ON THE ISLE LLC
creative, tailored solutions to its senior living clientele, including investment banking, financial risk management, merger and acquisition services, seed capital, FHA/HUD, capital and strategic planning as well as senior living research, education, and communication.For more information about Ziegler,
More news about: Ziegler
Jan 07, 2026, 09:00 ET Oasys Raises $4.6M to Transform Mental Health Care into a Data-Driven Discipline, Catalyzing Better Health Outcomes
Oasys Health ("Oasys"), the first AI-native operating system for behavioral health, today announces $4.6M in funding, including a $4M seed round led by
More news about: Oasys Health
Jan 07, 2026, 08:33 ET Korea University Researchers Discover That Cholesterol-lowering Drug Can Overcome Chemotherapy Resistance in Triple-Negative Breast Cancer
chemotherapy. Despite initial responsiveness, many patients experience rapid relapse driven by cancer stem-like cells that survive chemotherapy and seed metastasis.Addressing this unmet need, researchers led by Professor Jae Hong Seo from Korea University have discovered that pitavastatin, a widely
More news about: Korea University College of Medicine
Jan 07, 2026, 08:23 ET 2025's Top Accounting Solutions Ranked by Info-Tech Research Group for Financial Insight and Operational Efficiency
Accounting Seed, 8.1 CS, ranked high for its accounts payable and purchase order capabilities.
More news about: Info-Tech Research Group
Jan 07, 2026, 08:15 ET AGCO Brands Win Seven 2026 AE50 Awards
Precision Planting® MiraSense™ is an advanced optical seed sensor that uses optimized LEDs and firmware to accurately detect a wide range of seed sizes, eliminating the need to switch sensors between crops. Its dust rejection algorithm distinguishes seeds
More news about: AGCO Corporation
Jan 07, 2026, 08:00 ET STRM.BIO Raises $8 Million in Series Seed 2 Financing to Advance Non-Viral Gene Delivery Platform for In Vivo Cell Engineering and Gene Therapy
today announced $8 million in Series Seed 2 financing. The financing provided by Recordati was supported by continued participation by existing investors Boehringer Ingelheim Ventures and Delos Capital, as well as new funding from Blue Bay Capital Fund. The Series Seed 2 round remains open, with the intent
More news about: STRM.BIO
Jan 07, 2026, 06:01 ET Target Launches a New Era in Wellness, Strengthening its Leadership as the Destination for Trend-Forward Products and Everyday Wellbeing
deepening its assortment with brands like Cymbiotika, Arrae and The Coconut Cult, and new options from Lemme, Grüns and Seed.Functional and non-alcoholic beverages: As guests reach for drinks with benefits beyond hydration, the retailer is adding functional
More news about: Target Corporation
Jan 07, 2026, 06:00 ET Corteva and bp Launch Biofuel Feedstock Joint Venture Etlas™
biofuels like sustainable (or synthetic) aviation fuel (SAF) and renewable diesel (RD). Etlas will harness both Corteva's century-long expertise in seed technology to develop crops ideally suited to produce SAF and RD as well as bp's expertise in refining and marketing fuel for the commercial transportation
More news about: Corteva Agriscience
Jan 07, 2026, 03:01 ET BioSpace Names 15 Top Startups to Watch in 2026
multiple factors: financing, collaborations, pipeline, growth potential and innovation. This year's list includes companies that announced initial, seed or series A rounds between October 1, 2024, and September 30, 2025."Startups faced a challenging funding and regulatory environment in 2025,"
More news about: BioSpace
Jan 06, 2026, 13:00 ET Aquablu Makes U.S. Debut at CES 2026 with 'Aquablu BOLD', Launching Personalized Hydration at Scale
€7 million seed round led by Frans van Houten, former CEO of Philips. Aquablu has been recognized as one of Europe's fastest-growing companies and has received
More news about: Aquablu
Jan 06, 2026, 12:00 ET Verdesian Life Sciences Celebrates a Year of Giving with More Than 1,500 Volunteer Hours in 2025
SCIENCESVerdesian Life Sciences ("Verdesian") is a global leader in nutrient use efficiency (NUE), providing fertilizer enhancers, biologicals, nutritionals, seed treatments, inoculants, and biostimulants for row crops, specialty crops, and turf and ornamental markets. Backed by decades of research and real-world
More news about: Verdesian Life Sciences
Jan 06, 2026, 11:00 ET LMArena Raises $150 Million to Build the World's Most Trusted AI Evaluation Platform
today announced it has raised $150 million in new funding, achieving a post-money valuation of $1.7 billion, nearly triple the valuation following its seed round in May 2025. Funding was led by Felicis and UC Investments (University of California), with participation from Andreessen Horowitz, The House
More news about: LMArena
Jan 06, 2026, 10:30 ET Cell Culture Reagents Market worth $8.95 billion by 2030 | MarketsandMarkets™
moving from development into clinical and commercial manufacturing, which drive repeat consumption of media, feeds, supplements, and buffers across the seed train and production.The Asia Pacific is expected to be the fastest-growing region in the global cell culture reagents market during the forecast
More news about: MarketsandMarkets
Jan 06, 2026, 09:28 ET Dark Blue Therapeutics acquired by Amgen for up to $840 million
vulnerabilities and dependencies in cancer. The MLLT 1/3 programme's scientific foundation is rooted in unique insights from Oxford University and was awarded pre-seed funding from the 'LAB282' initiative. Dark Blue has been strongly supported by investors Oxford Science Enterprises (OSE), Bristol Myers Squibb (BMS)
More news about: Dark Blue Therapeutics
Jan 06, 2026, 09:01 ET ILIA Beauty Launches Overglaze Hydrating Lip Gloss: The Latest Innovation in Clean Beauty
skin-improving ingredients that deliver clinically proven, 24-hour hydration, leaving lips noticeably fuller and smoother. The product is powered by Fenugreek Seed Extract, a moisture-boosting botanical that nourishes, softens, and helps visibly plump the lips with lasting hydration, and sustainably sourced Seaweed
More news about: ILIA Beauty
Jan 06, 2026, 09:00 ET Burger King® Kicks Off the Year with a New Guest-Inspired Creation: The Ultimate Steakhouse Whopper®
The Ultimate Steakhouse Whopper features 4.4 oz* of 100% flame-grilled beef, served on a toasted sesame seed bun and stacked with golden onion rings, crispy bacon, sautéed mushrooms, melty Swiss cheese, and creamy peppercorn aioli. Each bite delivers rich,
More news about: Burger King
Jan 06, 2026, 08:08 ET Tesoro XP Raises $5.4M Seed Round to Build the First Retail-Funded Rewards Platform for Free-to-Play Games
Tesoro XP, a new rewards platform that enables retailers to fund in-game currency for gamers, announced it has raised $5.4 million in seed funding. The round was co-led by Treasury, a New York–based fintech fund, and TK MediaTech Ventures, a new venture firm focused on the
More news about: Tesoro XP
Jan 06, 2026, 08:00 ET Corteva Announces Dates for Fourth Quarter 2025 Earnings Release and Webcast
challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned
More news about: Corteva Agriscience
Jan 06, 2026, 03:30 ET LoQus23 Therapeutics nominates LQT-23 as first-in-class, oral drug candidate for Huntington's Disease
Benn, and Dr Ruth McKernan CBE, FMedSci, Entrepreneurs in Residence at SV Health Investors' Dementia Discovery Fund, which also acted as the initial seed investor. In October 2024, the Company closed a successful £35 million Series A financing round led by Forbion, alongside existing investors SV Health
More news about: LoQus23 Therapeutics